Fatal outcome after postexposure rabies vaccination in a patient with Parkinson’s disease | Zendy

Dušan Lalošević | Zendy; Vesna Lalošević | Zendy; Milorad Saric | Zendy; Jasenka Mazibrada | Zendy; Siniša Babović | Zendy; Slobodan Sekulić | Zendy; Zorica Mitic | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fatal outcome after postexposure rabies vaccination in a patient with Parkinson’s disease

Author(s) -

Dušan Lalošević,

Vesna Lalošević,

Milorad Saric,

Jasenka Mazibrada,

Siniša Babović,

Slobodan Sekulić,

Zorica Mitic

Publication year - 2004

Publication title -

medicinski pregled

Language(s) - English

Resource type - Journals

eISSN - 1820-7383

pISSN - 0025-8105

DOI - 10.2298/mpns0410487l

Subject(s) - rabies , medicine , direct fluorescent antibody , autopsy , vaccination , virology , immunofluorescence , parkinsonism , antibody , immunology , pathology , disease

In Serbia and Montenegro postexposure rabies vaccination is performed using five doses of rabies vaccine with a potency of 2.5 I.U. It is given on 0, 3rd, 7th, 14th and 28th day, combined with human rabies immunoglobulin with the first dose. Modern rabies vaccines produced in cell cultures rarely cause neurologic complications, among which Guillain-Barre syndrome and parkinsonism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research